Term ends May 13, 2035 · High confidence
20-year base term ends May 13, 2035
Held by Sanofi
Filed Mar 29, 2021 as application 17/215,039 · Granted Apr 26, 2022
Base term, 20 years from filing
Today
2015
2035
Clock starts
May 13, 2015
May 13, 2015
Term ends
May 13, 2035
May 13, 2035
Granted
Apr 26, 2022
Apr 26, 2022
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,142,569, US 11,319,364, US 11,485,777, US 12,180,268, to May 13, 2035. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
13
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 13, 2015, when application PCT/EP2015/060643, the earliest non-provisional in its chain, was filed (this one was filed Mar 29, 2021) | May 13, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,142,569, US 11,319,364, US 11,485,777, US 12,180,268) | resolves to May 13, 2035, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 13, 2035 | High confidence |
This family
| US 12,180,268 | In force May 2035 | May 2035 |
| US 11,312,764 | In force May 2035 | May 2035 |
| US 11,220,539 | In force May 2035 | May 2035 |
| US 11,485,777 | In force May 2035 | May 2035 |
| US 11,319,364 | Surrendered on reissue Dec 2025 | Dec 2025 |
| US 11,312,765 | this patent May 2035 | May 2035 |
| US 11,485,778 | In force May 2035 | May 2035 |
| US 12,723,072 | In force May 2035 | May 2035 |
8 of 13 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 16, 2021 Reel 57190, frame 283 | Buyse, Marie-ange; Boutton, Carlo | Ablynx N.V. | Assignment of Assignor's Interest |
| May 10, 2022 Reel 59883, frame 339 | Ablynx N.V. | Sanofi | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2035
Term ends May 13, 2035. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,142,569, US 11,319,364, US 11,485,777, US 12,180,268, ends no earlier than this term, so it caps nothing.
Citations
13
later US patents cite this one
That is top 10% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.